前列地尔是一种药物,可用于所有三种方式。
目的:了解前列地尔注射液的临床应用现状。
Objective To understand the recently clinical usage of alprostadil injection.
目的探讨降低前列地尔注射液所致静脉炎的输液方式。
Objective to explore the infusion methods to reduce phlebitis caused by alprostadil injection.
目的:比较前列地尔与传统方法治疗突发性耳聋的临床疗效。
OBJECTIVE: To compare the clinical effects between alprostadil and the traditional therapy in treating sudden deafness.
目的观察前列地尔(PGE-1)联合奥扎格雷治疗急性脑梗死的疗效。
Objective To observe the clinical efficacy of PGE-1 combined with Ozagrel in treating acute cerebral infarction.
目的探讨前列地尔联合还原型谷胱甘肽治疗药物性急性肾损害的临床疗效。
Objective To study the effects of Alprosladil and Glutathione therapy on patients with drug-induced acute renal damage.
目的:观察生脉注射液联合前列地尔注射液治疗糖尿病周围神经病变的临床疗效。
Objective: To investigate the clinical effect of Shengmai injection combined with alprostadil injection on diabetes peripheral neuropathy.
观察和分析苦碟子联合前列地尔治疗早期糖尿病肾病的临床疗效,总结其临床价值。
To observe and analyze the China Ixeris combine with alprostadil in the treatment of early diabetic nephropathy and summarize its clinical value.
在对症治疗的基础上,对照组给予前列地尔,观察组采用补气益肾降浊汤联合前列地尔。
On the basis of active treatment to symptoms, the control one took Qianlie Dier, the observation one decoction nourishing Qi and blood and reducing turbid together with Qianlie Dier.
结论:在常规治疗的基础上加用前列地尔注射液联合生脉注射液治疗不稳定型心绞痛,疗效显著。
Conclusion: it is quite effective, on the basis of routine treatment, adding Alprostadil with Pulse-activating injection in the treatment of the patients with UAP.
该前列地尔纳米脂质载体由治疗有效量的前列地尔、固态脂质材料、液态油、乳化剂、PEG修饰的酯类和注射用水组成。
The alprostadil nanometer lipid carrier consists of an effective doses of alprostadil, solid lipid material, liquid oil, emulsifier, PEG modified esters and water for injection.
该前列地尔纳米脂质载体由治疗有效量的前列地尔、固态脂质材料、液态油、乳化剂、PEG修饰的酯类和注射用水组成。
The alprostadil nanometer lipid carrier consists of an effective doses of alprostadil, solid lipid material, liquid oil, emulsifier, PEG modified esters and water for injection.
应用推荐